Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.

Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling C, Wong JA, Wright DJ, Zarraga IG, Coutts SB, Kaplan A, Pombo M, Ayala-Paredes F, Xu L, Simek K, Nevills S, Mian R, Connolly SJ, ARTESIA Investigators

Open source

DOI
10.1056/nejmoa2310234
Published
2024 Jan 11
Container
The New England journal of medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2310234,
  title = {Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.},
  author = {Healey JS and Lopes RD and Granger CB and Alings M and Rivard L and McIntyre WF and Atar D and Birnie DH and Boriani G and Camm AJ and Conen D and Erath JW and Gold MR and Hohnloser SH and Ip J and Kautzner J and Kutyifa V and Linde C and Mabo P and Mairesse G and Benezet Mazuecos J and Cosedis Nielsen J and Philippon F and Proietti M and Sticherling C and Wong JA and Wright DJ and Zarraga IG and Coutts SB and Kaplan A and Pombo M and Ayala-Paredes F and Xu L and Simek K and Nevills S and Mian R and Connolly SJ and ARTESIA Investigators},
  year = {2024},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2310234},
  url = {https://doi.org/10.1056/nejmoa2310234}
}

RIS

TY  - JOUR
TI  - Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
AU  - Healey JS
AU  - Lopes RD
AU  - Granger CB
AU  - Alings M
AU  - Rivard L
AU  - McIntyre WF
AU  - Atar D
AU  - Birnie DH
AU  - Boriani G
AU  - Camm AJ
AU  - Conen D
AU  - Erath JW
AU  - Gold MR
AU  - Hohnloser SH
AU  - Ip J
AU  - Kautzner J
AU  - Kutyifa V
AU  - Linde C
AU  - Mabo P
AU  - Mairesse G
AU  - Benezet Mazuecos J
AU  - Cosedis Nielsen J
AU  - Philippon F
AU  - Proietti M
AU  - Sticherling C
AU  - Wong JA
AU  - Wright DJ
AU  - Zarraga IG
AU  - Coutts SB
AU  - Kaplan A
AU  - Pombo M
AU  - Ayala-Paredes F
AU  - Xu L
AU  - Simek K
AU  - Nevills S
AU  - Mian R
AU  - Connolly SJ
AU  - ARTESIA Investigators
PY  - 2024
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2310234
UR  - https://doi.org/10.1056/nejmoa2310234
ER  - 

APA

JS, H., RD, L., CB, G., M, A., L, R., WF, M., D, A., DH, B., G, B., AJ, C., D, C., JW, E., MR, G., SH, H., J, I., J, K., V, K., C, L., P, M., G, M., J, B. M., J, C. N., F, P., M, P., C, S., JA, W., DJ, W., IG, Z., SB, C., A, K., M, P., F, A., L, X., K, S., S, N., R, M., SJ, C., & Investigators, A. (2024). Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2310234

Source records